18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma-Reference-Cited by-同舟云学术

18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma

Published:2010-08-18 Issue:9 Volume:51 Page:1337-1343
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Cerci Juliano J.,Pracchia Luís F.,Linardi Camila C.G.,Pitella Felipe A.,Delbeke Dominique,Izaki Marisa,Trindade Evelinda,Junior José Soares,Buccheri Valeria,Meneghetti José C.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Eghbali H Raemaekers J Carde P ; EORTC Lymphoma Group. The EORTC strategy in the treatment of Hodgkin's lymphoma. Eur J Haematol Suppl. 2005;(66):135–140.

2. PET and PET/CT for response evaluation in lymphoma: Current practice and developments

3. Diehl V Mauch P Harris NL . Hodgkin's disease. In: De Vita V , ed. Cancer Principles and Practice of Oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2001;2339–2387.

4. Mauch P Armitage JP Diehl V . Hodgkin's Disease . Philadelphia, PA: Lippincott Williams & Wilkins; 1999;223–240.

5. Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and validation of an ¹⁸ F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients;Hematology;2024-03-15

2. The Prognostic Role of [¹⁸F]FDG PET/CT in Patients with Advanced Cutaneous Squamous Cell Carcinoma Submitted to Cemiplimab Immunotherapy: A Single-Center Retrospective Study;Cancer Biotherapy and Radiopharmaceuticals;2023-10-26

3. Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma;Annals of Hematology;2023-10-05

4. Imaging Recommendations for Diagnosis, Staging, and Management of Hematological Malignancies;Indian Journal of Medical and Paediatric Oncology;2023-05-12

5. Interim FDG-PET/CT for Response Assessment of Lymphoma;Seminars in Nuclear Medicine;2023-05